| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1055/S-0031-1276585 |
| P698 | PubMed publication ID | 21805442 |
| P2093 | author name string | Sacha Zeerleder | |
| P433 | issue | 4 | |
| P304 | page(s) | 362-374 | |
| P577 | publication date | 2011-06-01 | |
| P1433 | published in | Seminars in Thrombosis and Hemostasis | Q15751825 |
| P1476 | title | C1-inhibitor: more than a serine protease inhibitor | |
| P478 | volume | 37 |
| Q47180647 | 2D-LC-MS/MS to measure cleaved high-molecular-weight kininogen in human plasma as a biomarker for C1-INH-HAE. |
| Q31132259 | C1 esterase inhibitor reduces lower extremity ischemia/reperfusion injury and associated lung damage |
| Q44198286 | C1-inhibitor efficiently inhibits Escherichia coli-induced tissue factor mRNA up-regulation, monocyte tissue factor expression and coagulation activation in human whole blood |
| Q55262251 | Complement Activation During Ischemia/Reperfusion Injury Induces Pericyte-to-Myofibroblast Transdifferentiation Regulating Peritubular Capillary Lumen Reduction Through pERK Signaling. |
| Q35197120 | Complement evasion by Bordetella pertussis: implications for improving current vaccines |
| Q33432423 | Complement in disease: a defence system turning offensive |
| Q36756854 | Complement in immune and inflammatory disorders: therapeutic interventions |
| Q26777628 | Complement inhibitors to treat IgM-mediated autoimmune hemolysis |
| Q36144212 | Comprehensive study into the activation of the plasma enzyme systems during attacks of hereditary angioedema due to C1-inhibitor deficiency |
| Q36010575 | Dynamics of hepatic gene expression profile in a rat cecal ligation and puncture model |
| Q90174208 | Effect of C1-inhibitor in adults with mild asthma: A randomized controlled trial |
| Q46016736 | Evaluating the efficacy of subcutaneous C1-esterase inhibitor administration for use in rat models of inflammatory diseases. |
| Q38790498 | Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment |
| Q38037555 | Host- and microbe determinants that may influence the success of S. aureus colonization |
| Q36783613 | How it all starts: Initiation of the clotting cascade. |
| Q42695895 | Human plasma-derived C1 esterase inhibitor concentrate has limited effect on house dust mite-induced allergic lung inflammation in mice. |
| Q47316465 | Kallikrein Cleaves C3 and Activates Complement. |
| Q41821623 | Nebulized C1-Esterase Inhibitor does not Reduce Pulmonary Complement Activation in Rats with Severe Streptococcus Pneumoniae Pneumonia. |
| Q36361422 | Neutrophil activation during attacks in patients with hereditary angioedema due to C1-inhibitor deficiency |
| Q33602320 | New milestones ahead in complement-targeted therapy |
| Q34980897 | Ongoing contact activation in patients with hereditary angioedema |
| Q38247280 | Peptide inhibitor of complement c1, a novel suppressor of classical pathway activation: mechanistic studies and clinical potential. |
| Q51728163 | Plasma-derived human C1-esterase inhibitor does not prevent mechanical ventilation-induced pulmonary complement activation in a rat model of Streptococcus pneumoniae pneumonia. |
| Q41663740 | Polyphosphate is a novel cofactor for regulation of complement by a serpin, C1 inhibitor. |
| Q37535268 | Polyphosphate suppresses complement via the terminal pathway |
| Q36479278 | Progress and Trends in Complement Therapeutics |
| Q38163242 | Protein engineering to target complement evasion in cancer |
| Q38047647 | Role of serine proteases in inflammation: Bowman-Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases |
| Q64087538 | Significance of Complement System in Ischemic Stroke: A Comprehensive Review |
| Q47336749 | The renaissance of complement therapeutics. |
| Q41644232 | Treatment with anti-C5a antibody improves the outcome of H7N9 virus infection in African green monkeys |
Search more.